PIK3C2A and hypothyroidism: However, the absence of consistent fluctuations in laboratory data, such as increased cholesterol or CPK levels, suggests that the clinical diagnosis of hypothyroidism in patients receiving lenvatinib is challenging and primarily relies on TSH assays.